Fig. 4From: Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkersCumulative curve of antibiotic suspension. Time-to-event analysisBack to article page